Cost-Effectiveness and Budget Impact Analysis of the Trivalent Adjuvanted Influenza Vaccine in People over 50 Years of Age for Argentina
LJ Pastori,C. Silvestrini Viola,T. Alconada,G. Pereira, JL Montes, J. Mold-Quevedo,C. Saenz,N. Katz,A. Bardach and N. Espinola. Cost-Effectiveness and Budget Impact Analysis of the Trivalent Adjuvanted Influenza Vaccine in People over 50 Years of Age for Argentina. Vaccines. 2026;14(3):10.3390/vaccines14030227.

